We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reckitt Benckiser Group Plc | LSE:RB. | London | Ordinary Share | GB00B24CGK77 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6,498.00 | 6,502.00 | 6,506.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2006 15:51 | vassily, your'e not kidding. Some irrational exuberance going on here, silly PE, I'm going short soon. | bigbanker | |
26/7/2006 14:16 | Although earning per share is not perfect, one of the tipster in the mainstream UK press says eps has been decling for some time (a trend) and recommends take some profits. Not an unwise suggestions looking at the long-term chart. | vassily | |
24/7/2006 11:04 | Net revenues grew by 19% in Q2 to £1,224m (+17% constant) and by 18% in H1 to £ 2,386m (+15% constant). The underlying business (excluding BHI) grew 7% (6% constant) in Q2 and 8% (6% constant) in H1. BHI contributed net revenues of £127m in Q2 and £204m in H1. Restructuring costs for the BHI acquisition were £15m in Q2 and £57m in H1. Cost synergies from BHI in H1 were £11m, on track for the full year target of £30m. Operating profit before restructuring increased by 23% in Q2 to £228m and by 23% in H1 to £424m. Half Year gross margins improved by 130 basis points (bps) to 55.7%. Half year operating margins before restructuring improved 70bps to 17.8%. On an adjusted basis net income grew 13% in Q2 to £162m and 13% to £303m in H1. EPS diluted, adjusted grew 15% in Q2 to 22.1p, and 15% in H1 to 41.2p, growth rates benefiting from the share buyback program. Net borrowings were £795m compared with £825m at March 2006, reflecting continued strong cash flow offset by the payment of the final 2005 dividend and £48m share buybacks in Q2 (£93m in H1). The interim dividend will be increased to 20.5 pence per share, an increase of 14% and the Company is committed to its £300m share buyback program this year. 50% return since my last post ! | miata | |
09/5/2006 10:09 | that's a little better - tried to shake us out no doubt... | sea and sky | |
09/5/2006 09:06 | anyone know why the dip - except having gone ex-div. is this usual? | sea and sky | |
05/5/2006 08:50 | might be some support at 1950... | sea and sky | |
04/5/2006 20:24 | why the dip guys? | sea and sky | |
12/4/2006 09:23 | Tue 11-Apr-06 RB. Reckitt Benckiser Sell_at 2058 Stop_Loss 2089 Cls_Pr 2024 | davemake | |
09/4/2006 11:47 | Lehman Bros initiated coverage of Reckitt Benckiser shares with a "buy" rating and 2,500p target. | batman9 | |
15/3/2006 22:31 | captain11 - not the way the share price dropped today. | guru11 | |
07/3/2006 16:38 | -ucked today why the sudden rise. Strange also considering the stock is now gone XD | a4 | |
27/2/2006 13:47 | uber bull eh? | oospore | |
15/2/2006 12:52 | buying rb. woodabin better idea 4 a thread | oospore | |
06/1/2006 10:44 | Are you working for UBS? | aposto | |
05/1/2006 23:54 | £74 million pounds worth of shares dealt on the market today could hardly be described as negligible. Future plans for 2006 Shares in Reckitt Benckiser have been upgraded to buy from neutral at UBS, with an increased target of 2,000p In UBS' view, the negative share price reaction to Reckitt's slightly weaker than expected third quarter results has been overdone. This is all the more so, argued UBS, given like-for-like sales growth of 5.7% and margin progression of 30 basis points forecast for the full year and given that Reckitt continues to outperform its peers in a tough environment. At the full year results in February, UBS expects Reckitt to provide more detail on the acquisition of Boots Healthcare International (BHI), including the planned annual cost synergies of 75m, the expected working capital savings of 130m and potential sales synergies. 'Reckitt Benckiser sustained its robust growth ahead of the market resulting in our highest ever quarter for net revenues. Growth came across all regions and was strongly driven by new products like Cillit Bang, Finish 4in1, Air Wick Freshmatic and Vanish Oxi Action Max. Operating profit and net income improved in line with expectations despite the continuing pressure on input costs. To address this pressure, Reckitt Benckiser is implementing price increases in North America and Europe. 'The results confirm that Reckitt Benckiser is on track to deliver its full year targets of net revenue growth of 5% to 6% at constant exchange and net income growth in the mid teens on an adjusted IFRS base of £563m at actual exchange.' | batman9 | |
04/1/2006 10:18 | Yes fine but this is all about future plans for 2006 and the recent increase of over a pound on negligible volumes has nothing to do with continuous buybacks! | aposto | |
03/1/2006 11:46 | Re continuous buyback - Strong cash generation resulted in net funds of £714m at the end of Q3, an increase of £82m since last year-end, after share buybacks of £243m and dividends of £262m this year. The Company will complete its £300m share buyback program for 2005 and has confirmed its intention of a £300m buyback program in 2006. | batman9 | |
03/1/2006 09:37 | What continuous buyback. This is going up on 0 volumes, and in my opinion this is not healthy! | aposto | |
31/12/2005 18:57 | Over 20 % gain in a year and still not reached the 6 different brokers target price of between £20 & £20.50 - This cannot be classed as a mauling - If only all the rest of my shares performed in this way. With the acquisition and the continuing buy back there is no reason why £20.50 should easily be achieved. | batman9 | |
29/12/2005 16:39 | Taking a mauling, short big time | a4 | |
04/12/2005 21:20 | The analysis report on Yahoo, although the past graph has not look over impressive, do rate this stock as a buy rating, and the rating is lower than any other 100 top stock. So see how it goes. | guru11 | |
23/11/2005 08:44 | I agree with your analysis. I think there was a danger that the group was running out of steam but this acquisition is just what the doctor ordered and gives great opportunity for cost cutting and organic growth over the next 3 or 4 years. Becht is doing a great job | chanda46 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions